Search…

The concept of innovative drugs is repeatedly active, and Chenxin Pharmaceuticals has been limit-up for 8 consecutive days.

31/07/2025

The concept of innovative drugs is constantly active, with Chenxin Pharmaceuticals experiencing 8 consecutive days of hitting the daily limit, Shanghai Yizhong rising by 20cm, and Nanxin Pharmaceuticals and Ruizhi Pharmaceuticals rising by more than 10%. Asia-Pacific Pharmaceuticals, Jinshi Asia Pharmaceuticals, CR Double Crane Pharmaceuticals, and Aurit are among the top gainers.

Latest

1 m ago

Federal Reserve Chairman Powell: Both of our dual mandates are facing risks.

1 m ago

Federal Reserve Chairman Powell: The best thing we can do for the housing market is to stabilize home prices and achieve full employment.

2 m ago

Federal Reserve Chairman Powell: Commodities inflation has caused us to deviate slightly from our target, but the deviation is not significant.

2 m ago

Federal Reserve Chairman Powell said that a decision has not been made yet on whether to cut interest rates in September, and as a result, the yield on US government bonds has increased. The yield on the 10-year Treasury bond has risen by 4.6 basis points to 4.372%.

2 m ago

The U.S. Department of the Treasury website's announcement: The United States has issued a new general license related to Iran, authorizing certain transactions and allowing the offloading of goods from specific individuals or vessels blocked on July 30th.

See all latest